Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-03 Sale |
2025-01-07 5:20 pm |
Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer |
6,502 | $12.18 | $79,194 | 59,878 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 4:46 pm |
Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer |
3,877 | $29.46 | $114,216 | 36,987 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-06 5:29 pm |
Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer |
1,812 | $37.21 | $67,425 | 17,306 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-01 Option Award |
2024-03-05 4:10 pm |
N/A 2034-02-28 |
Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer |
71,814 | $0 | 108,801 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:31 pm |
N/A 2033-02-28 |
Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer |
56,845 | $0 | 74,151 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:15 pm |
N/A 2032-01-02 |
Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer |
44,118 | $0 | 44,118 (Direct) |
View |